View in EDS

Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data.

Saved in:
Bibliographic Details
Title: Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data.
Authors: Epstein S; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA. Electronic address: see2132@cumc.columbia.edu., Xia Z; University of Pittsburgh; Department of Neurology; Pittsburgh, PA, USA., Lee AJ; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA., Dahl M; University of Pittsburgh; Department of Neurology; Pittsburgh, PA, USA., Edwards K; The Multiple Sclerosis Center of Northeastern New York; Latham, NY, USA., Levit E; Yale University School of Medicine; Department of Neurology; New Haven, CT, USA., Longbrake EE; Yale University School of Medicine; Department of Neurology; New Haven, CT, USA., Perrone C; University of Pennsylvania School of Medicine; Department of Neurology; Philadelphia, PA, USA., Kavak K; State University of New York at Buffalo; Department of Neurology; Buffalo, NY, USA., Weinstock-Guttman B; State University of New York at Buffalo; Department of Neurology; Buffalo, NY, USA., Diallo F; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA., Ricci A; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA., Riley CS; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA., De Jager PL; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA., Farber R; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA., Wesley SF; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA.
Corporate Authors: Multiple Sclerosis Resilience to COVID-19 (MSReCOV) Collaborative
Source: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2022 Jan; Vol. 57, pp. 103433. Date of Electronic Publication: 2021 Dec 02.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34923427
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Epstein+S%22">Epstein S</searchLink>; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA. Electronic address: see2132@cumc.columbia.edu.<br /><searchLink fieldCode="AU" term="%22Xia+Z%22">Xia Z</searchLink>; University of Pittsburgh; Department of Neurology; Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+AJ%22">Lee AJ</searchLink>; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Dahl+M%22">Dahl M</searchLink>; University of Pittsburgh; Department of Neurology; Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Edwards+K%22">Edwards K</searchLink>; The Multiple Sclerosis Center of Northeastern New York; Latham, NY, USA.<br /><searchLink fieldCode="AU" term="%22Levit+E%22">Levit E</searchLink>; Yale University School of Medicine; Department of Neurology; New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Longbrake+EE%22">Longbrake EE</searchLink>; Yale University School of Medicine; Department of Neurology; New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Perrone+C%22">Perrone C</searchLink>; University of Pennsylvania School of Medicine; Department of Neurology; Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Kavak+K%22">Kavak K</searchLink>; State University of New York at Buffalo; Department of Neurology; Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Weinstock-Guttman+B%22">Weinstock-Guttman B</searchLink>; State University of New York at Buffalo; Department of Neurology; Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Diallo+F%22">Diallo F</searchLink>; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ricci+A%22">Ricci A</searchLink>; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Riley+CS%22">Riley CS</searchLink>; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22De+Jager+PL%22">De Jager PL</searchLink>; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Farber+R%22">Farber R</searchLink>; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Wesley+SF%22">Wesley SF</searchLink>; Multiple Sclerosis Center and the Center For Translational & Computational Neuroimmunology, Columbia University Irving Medical Center; Department of Neurology. New York, NY, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Multiple+Sclerosis+Resilience+to+COVID-19+%28MSReCOV%29+Collaborative%22">Multiple Sclerosis Resilience to COVID-19 (MSReCOV) Collaborative</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101580247%22">Multiple sclerosis and related disorders</searchLink> [Mult Scler Relat Disord] 2022 Jan; Vol. 57, pp. 103433. <i>Date of Electronic Publication: </i>2021 Dec 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2E+V%22">Elsevier B. V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101580247 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2211-0356 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222110348%22">22110348 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler Relat Disord <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34923427
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.msard.2021.103433
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 103433
    Titles:
      – TitleFull: Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Epstein S
      – PersonEntity:
          Name:
            NameFull: Xia Z
      – PersonEntity:
          Name:
            NameFull: Lee AJ
      – PersonEntity:
          Name:
            NameFull: Dahl M
      – PersonEntity:
          Name:
            NameFull: Edwards K
      – PersonEntity:
          Name:
            NameFull: Levit E
      – PersonEntity:
          Name:
            NameFull: Longbrake EE
      – PersonEntity:
          Name:
            NameFull: Perrone C
      – PersonEntity:
          Name:
            NameFull: Kavak K
      – PersonEntity:
          Name:
            NameFull: Weinstock-Guttman B
      – PersonEntity:
          Name:
            NameFull: Diallo F
      – PersonEntity:
          Name:
            NameFull: Ricci A
      – PersonEntity:
          Name:
            NameFull: Riley CS
      – PersonEntity:
          Name:
            NameFull: De Jager PL
      – PersonEntity:
          Name:
            NameFull: Farber R
      – PersonEntity:
          Name:
            NameFull: Wesley SF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2022 Jan
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2211-0356
          Numbering:
            – Type: volume
              Value: 57
          Titles:
            – TitleFull: Multiple sclerosis and related disorders
              Type: main
ResultId 1